What Makes GPS Cancer Different from Other Genomic Tests?
Unlike other genomic tests that may focus solely on DNA sequencing, GPS Cancer provides a more holistic view by also including RNA sequencing and proteomic analysis. This multi-dimensional approach allows for a deeper understanding of the tumor's biology, which can lead to more accurate and effective treatment recommendations. Additionally, GPS Cancer is backed by NantHealth's extensive database of cancer research and clinical data, ensuring that the insights provided are both current and relevant.
